<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CVTS REPORT</title>
    <style>
        :root {
            --accent: #f47d24;
            --text: #222222;
            --bg: #f5f5f5;
            --white: #ffffff;
        }

        body {
            margin: 0;
            font-family: "Inter", system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
        }

        p {
            text-align: justify;
        }

        /* header layout - UPDATED FOR STACKED LAYOUT */
        .top-bar {
            display: flex;
            flex-direction: column;
            /* This stacks the blocks vertically */
            align-items: center;
            /* This centers the blocks */
            justify-content: center;
            padding: 18px 48px;
            background: var(--white);
            border-bottom: 4px solid var(--accent);
            box-shadow: 0 4px 16px rgba(0, 0, 0, 0.06);

            position: sticky;
            top: 0;
            z-index: 1000;
        }

        /* left side: logos + title */
        .brand-block {
            display: flex;
            align-items: center;
            gap: 24px;
            /* Ensure the block takes full width to help centering if needed, 
               or keep it auto to stay compact */
            margin-bottom: 16px;
            /* Adds space between Title and Nav */
        }

        .brand-logos {
            display: flex;
            flex-direction: column;
            gap: 6px;
        }

        .brand-logo {
            width: 170px;
            /* Reduced slightly to save vertical space in sticky header */
            height: auto;
        }

        /* vertical accent line between logos and title */
        .brand-divider {
            width: 2px;
            height: 56px;
            background: var(--accent);
            border-radius: 999px;
        }



        /* nav links */
        .nav-links {
            display: flex;
            gap: 28px;
            font-weight: 500;
            width: 100%;
            justify-content: center;
            /* Centers the links horizontally */
            padding-top: 10px;
            border-top: 1px solid #eee;
            /* Optional: Adds a subtle divider line */
        }

        .nav-links a {
            position: relative;
            text-decoration: none;
            color: var(--accent);
            font-size: 0.98rem;
        }

        /* subtle underline hover */
        .nav-links a::after {
            content: "";
            position: absolute;
            left: 0;
            bottom: -6px;
            width: 0;
            height: 2px;
            background: var(--accent);
            transition: width 0.2s ease-out;
        }

        .nav-links a:hover::after {
            width: 100%;
        }

        /* page title section */
        main {
            max-width: 960px;
            margin: 48px auto;
            padding: 32px 40px;
            background: var(--white);
            border-radius: 12px;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.06);
        }

        main h2 {
            text-align: left;
            margin: 0;
            font-family: "Montserrat", system-ui, sans-serif;
        }

        /* report title */
        .report-name {
            margin: 0;
            font-family: "Montserrat", system-ui, sans-serif;
            font-size: 1.6rem;
            letter-spacing: 0.08em;
            text-transform: uppercase;
            color: var(--accent);
        }

        .report-main {
            max-width: 100%;
            margin: 32px 0 64px;
            padding: 0 64px 32px;
            /* side + bottom padding */
            background: #f5f5f5;
            /* light page background */
            box-sizing: border-box;
        }

        /* individual cards */
        .report-card {
            background: #ffffff;
            border-radius: 12px;
            padding: 24px 28px;
            margin-top: 24px;
            box-shadow: 0 10px 24px rgba(54, 53, 53, 0.06);
        }

        /* spacing rhythm between cards */
        .report-card+.report-card {
            margin-top: 24px;
        }

        /* headings and text inside cards */
        .report-card h2 {
            margin: 0 0 12px;
            font-size: 1.25rem;
            letter-spacing: 0.05em;
            text-transform: uppercase;
            color: #070300;
        }

        .report-card p {
            margin: 0;
            font-size: 0.98rem;
            line-height: 1.6;
            color: #333333;
        }

        .summary-table {
            border-collapse: collapse;
            width: 100%;
            padding: 2%;
            font-size: 0.95rem;
            background-color: #e8e8e89f;
        }

        .summary-table caption {
            text-align: center;
            font-weight: 800;
            margin-bottom: 6px;
            background-color: #dddddd;
        }

        /* 1. General Rule: Default to Right Alignment (for numbers) */
        .summary-table th,
        .summary-table td {
            text-align: right;
            /* Numeric values and numeric headers go right */
            padding: 6px 12px;
            /* Adjusted padding for better readability */
            border-bottom: 1px solid #e0e0e0;
            /* Optional: adds subtle separation */
        }

        /* 2. Specific Rule: First Column Only (for text labels) */
        .summary-table th:first-child,
        .summary-table td:first-child {
            text-align: left;
            /* Text labels and text headers go left */
        }

        /* Optional: Ensure the caption stays centered or left as preferred */
        .summary-table caption {
            text-align: center;
            font-weight: 800;
            margin-bottom: 8px;
            padding: 8px;
            background-color: #dddddd;
        }

        /* light bottom line between tbody blocks */
        .summary-table tbody.section {
            border-top: 1px solid #dddddd;
            margin-top: 4px;
            /* visual gap (via border) */
        }

        .chart {
            margin: 24px auto;
            text-align: center;
        }

        .chart img {
            max-width: 100%;
            height: auto;
            display: block;
            margin: 0 auto;
        }

        .figure-row {
            display: flex;
            flex-wrap: wrap;
            gap: 16px;
            justify-content: space-between;
        }

        /* each figure takes about half the row, but can shrink */
        .figure-row .chart {
            flex: 1 1 calc(50% - 16px);
            /* two per row */
            max-width: calc(50% - 16px);
            margin: 0;
        }

        .figure-row .chart img {
            width: 100%;
            /* scale image down to fit */
            height: auto;
            display: block;
        }

        .chart figcaption {
            margin-top: 8px;
            font-size: 0.85rem;
            color: #555555;
            font-style: italic;
            text-align: center;
        }

        /* Interactive Plot Styles */
        .interactive-container {
            background: #f9f9f9;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 20px;
            margin-bottom: 24px;
        }

        .control-row {
            display: flex;
            gap: 20px;
            margin-bottom: 16px;
            flex-wrap: wrap;
        }

        .control-group {
            display: flex;
            flex-direction: column;
            gap: 6px;
            flex: 1;
            min-width: 250px;
        }

        .control-group label {
            font-size: 0.85rem;
            font-weight: 600;
            color: var(--accent);
            text-transform: uppercase;
        }

        .control-group select {
            padding: 10px;
            border: 1px solid #ccc;
            border-radius: 6px;
            font-family: inherit;
            font-size: 0.95rem;
            background-color: white;
            cursor: pointer;
        }

        .control-group select:focus {
            outline: none;
            border-color: var(--accent);
            box-shadow: 0 0 0 2px rgba(244, 125, 36, 0.2);
        }

        #plot-frame {
            width: 100%;
            height: 500px;
            border: 1px solid #ddd;
            border-radius: 4px;
            background: white;
            display: block;
        }
    </style>
    <script>
        document.addEventListener('DOMContentLoaded', function () {
            const procSelect = document.getElementById('procedure-select');
            const measureSelect = document.getElementById('measure-select');
            const plotFrame = document.getElementById('plot-frame');
            function updatePlot() {
                const procId = procSelect.value;
                const measureId = measureSelect.value;
                if (procId && measureId) {
                    // Constructs URL: plots/PROCEDUREID_MEASUREMENTID.html
                    // You can change the extension to .png or .jpg if you are serving static images instead.
                    const plotUrl = `plot/${procId}_${measureId}.html`;
                    plotFrame.src = plotUrl;
                }
            }
            procSelect.addEventListener('change', updatePlot);
            measureSelect.addEventListener('change', updatePlot);
        });
    </script>

</head>

<body>
    <div id="password-overlay">
        <div class="login-box">
            <div class="brand-block" style="justify-content: center; margin-bottom: 20px;">
                <div class="brand-logos" style="flex-direction: row; align-items: center;">
                    <img src="bridgecloud.svg" alt="Bridge Cloud" class="brand-logo" style="height: 40px; width: auto;">
                    <div style="width: 2px; height: 30px; background: #f47d24; margin: 0 10px;"></div>
                    <img src="miimansa.svg" alt="Miimansa" class="brand-logo" style="height: 40px; width: auto;">
                </div>
            </div>
            <h2 style="text-align: center; color: var(--text); margin-top: 0;">Restricted Access</h2>
            <p style="text-align: center; margin-bottom: 20px;">Please enter the password to view this report.</p>

            <input type="password" id="password-input" placeholder="Enter Password" onkeyup="checkForEnter(event)">
            <p id="error-message">Incorrect password</p>
            <button onclick="checkPassword()">View Report</button>
        </div>
    </div>

    <style>
        /* Stop the page from scrolling while locked */
        body.locked {
            overflow: hidden;
        }

        /* Overlay Styles */
        #password-overlay {
            position: fixed;
            top: 0;
            left: 0;
            width: 100%;
            height: 100%;
            background-color: #f5f5f5;
            /* Matches your bg variable */
            z-index: 99999;
            /* Sits on top of everything */
            display: flex;
            justify-content: center;
            align-items: center;
        }

        .login-box {
            background: white;
            padding: 40px;
            border-radius: 12px;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.1);
            width: 100%;
            max-width: 400px;
            border-top: 4px solid #f47d24;
            /* Matches your accent */
        }

        #password-input {
            width: 100%;
            padding: 12px;
            margin-bottom: 10px;
            border: 1px solid #ccc;
            border-radius: 6px;
            font-size: 1rem;
            box-sizing: border-box;
            /* Ensures padding doesn't break width */
        }

        #password-input:focus {
            outline: none;
            border-color: #f47d24;
        }

        .login-box button {
            width: 100%;
            padding: 12px;
            background-color: #f47d24;
            color: white;
            border: none;
            border-radius: 6px;
            font-size: 1rem;
            font-weight: bold;
            cursor: pointer;
            transition: background 0.2s;
        }

        .login-box button:hover {
            background-color: #d66a1b;
        }

        #error-message {
            color: red;
            font-size: 0.9rem;
            display: none;
            /* Hidden by default */
            text-align: center;
            margin-top: -5px;
            margin-bottom: 15px;
        }
    </style>

    <script>
        // 1. SET YOUR PASSWORD HERE
        const reportPassword = "cvts0987";

        // Lock body scroll immediately
        document.body.classList.add('locked');

        function checkPassword() {
            const input = document.getElementById('password-input').value;
            const errorMsg = document.getElementById('error-message');
            const overlay = document.getElementById('password-overlay');

            if (input === reportPassword) {
                // Unlock
                overlay.style.opacity = '0';
                setTimeout(() => {
                    overlay.style.display = 'none';
                    document.body.classList.remove('locked');
                }, 300); // smooth fade out
            } else {
                // Show error
                errorMsg.style.display = 'block';
                document.getElementById('password-input').value = '';
            }
        }

        // Allow pressing "Enter" key
        function checkForEnter(event) {
            if (event.key === "Enter") {
                checkPassword();
            }
        }
    </script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@500;700&family=Inter:wght@400;500&display=swap"
        rel="stylesheet">

    <header class="top-bar">
        <div class="brand-block">
            <div class="brand-logos">
                <img src="bridgecloud.svg" alt="Bridge Cloud" class="brand-logo">
                <img src="miimansa.svg" alt="Miimansa" class="brand-logo">
            </div>
            <div class="brand-divider"></div>
            <!-- <h1 class="report-name">CVTS Outcomes versus Length of Stay: Analysis of Real World Data from a Tertiary
                Care Facility</h1> -->
            <h1 class="report-name">
                CVTS Outcomes versus Length of Stay: <br>
                Analysis of Real World Data from a Tertiary Care Facility
            </h1>
        </div>

        <nav class="nav-links">
            <a href="#intro">Introduction</a>
            <a href="#objective">Objective</a>
            <a href="#data">Data</a>
            <a href="#methods">Methods</a>
            <a href="#results">Results</a>
            <a href="#conclusion">Conclusion</a>
        </nav>
    </header>


    <main class="report-main">
        <section id="intro" class="report-card">
            <h2>1. Introduction</h2>
            <!-- <p>Cardiovascular and thoracic surgery is a specialized medical field focused on the surgical treatment of
                conditions affecting the heart, lungs, and other thoracic cavity structures. The report demonstrates
                calculation of mortality rate, frequency or occurrence , distinct patient count and length of stay(los)
                over different medical procedure and different condition.</p> -->
            <p>
                Implementing Enhanced Recovery After Surgery (ERAS) protocols in cardiovascular and thoracic surgery
                (CVTS) is
                critical for optimizing recovery, yet these standards must be adapted using rigorous,
                population-specific data <a href="#ref1"
                    style="text-decoration: none; color: var(--accent); font-weight: bold;">[1]</a>.
                To the best of our knowledge, this report presents the first extensive characterization of CVTS outcomes
                and their
                association with Length of Stay (LOS) within an Indian patient population. By leveraging real-world
                clinical data,
                we aim to inform data-driven rehabilitation definitions that bridge the gap between global guidelines
                and local
                clinical reality.
            </p>
        </section>


        <section id="objective" class="report-card">
            <h2>2. Objective</h2>
            <p>
                The objective of this analysis is to <b>evaluate the relationship between post-operative Length of Stay
                    (LoS) and patient outcomes</b> in the Cardiovascular and Thoracic Surgery (CVTS) department, using
                real-world data derived from the OMOP Common Data Model.
                </br>
                Specifically, this analysis aims to:
            </p>
            <ul align="justify">
                <li><b>Assess whether shorter post-surgical hospital stays are associated with comparable or improved
                        clinical outcomes</b>, when measured against existing post-operative care guidelines.</li>
                <li><b>Examine outcome indicators</b> such as post-discharge complications, readmissions, mortality, and
                    need for re-intervention across varying Length of Stay categories.</li>
                <li><b>Identify patient subgroups</b> (based on age, procedure type, comorbidities, and peri-operative
                    risk factors) for whom early discharge may be clinically safe and effective.</li>
                <li><b>Generate evidence-based analysis</b> to support or challenge current guideline-driven Length of
                    Stay recommendations using institutional data.</li>
            </ul>
            <p>
                This analysis leverages longitudinal, standardized clinical data from approximately 1,000 CVTS patients,
                enabling an objective, outcome-focused evaluation of whether earlier discharge strategies can be safely
                considered without adversely impacting patient outcomes.
            </p>
        </section>


        <section id="data" class="report-card">
            <h2>3. Data</h2>
            <p>The dataset belongs to patient undergone Cardio Vascular Thoracic Surgery for headcount of 1147, the
                total visit occurrence was 9433 with cumulative IPD admissions of 1580.</p>
            <h3>3.1. Summary Statistics</h3>
            <table class="summary-table">
                <thead>
                    <tr>
                        <th scope="col">Metric</th>
                        <th scope="col">Value</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <th scope="row">Total Patients</th>
                        <td>1147</td>
                    </tr>
                    <tr>
                        <th scope="row">Male</th>
                        <td>666</td>
                    </tr>
                    <tr>
                        <th scope="row">Female</th>
                        <td>481</td>
                    </tr>
                </tbody>
                <tbody class="section">
                    <tr>
                        <th scope="row">Total Visits</th>
                        <td>9433</td>
                    </tr>
                    <tr>
                        <th scope="row">Total Procedure Types</th>
                        <td>27</td>
                    </tr>
                    <tr>
                        <th scope="row">Total Admission</th>
                        <td>1580</td>
                    </tr>
                    <tr>
                        <th scope="row">Deceased</th>
                        <td>90</td>
                    </tr>
                </tbody>
            </table>
            <h3>3.2. Surgical Procedures Analysed</h3>
            <table class="summary-table">
                <thead>
                    <tr>
                        <!-- <th scope="col">Procedure Concept ID</th> -->
                        <th scope="col">Procedure Name</th>
                        <th scope="col">Distinct Patient Count</th>
                        <th scope="col">Distinct Procedure Count</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <!-- <td>4012932</td> -->
                        <td>Atrioseptoplasty</td>
                        <td>162</td>
                        <td>170</td>
                    </tr>
                    <tr>
                        <!-- <td>4019929</td> -->
                        <td>Repair of Tetralogy of Fallot</td>
                        <td>33</td>
                        <td>36</td>
                    </tr>
                    <tr>
                        <!-- <td>4095407</td> -->
                        <td>Replacement of Aortic Valve</td>
                        <td>78</td>
                        <td>81</td>
                    </tr>
                    <tr>
                        <!-- <td>4142628</td> -->
                        <td>Pericardiectomy</td>
                        <td>32</td>
                        <td>35</td>
                    </tr>
                    <tr>
                        <!-- <td>4203153</td> -->
                        <td>Replacement of Mitral Valve</td>
                        <td>276</td>
                        <td>288</td>
                    </tr>
                    <tr>
                        <!-- <td>4284104</td> -->
                        <td>Aortocoronary Artery Bypass Graft</td>
                        <td>302</td>
                        <td>329</td>
                    </tr>
                    <tr>
                        <!-- <td>4294387</td> -->
                        <td>Correction of Ventricular Septal Defect</td>
                        <td>41</td>
                        <td>43</td>
                    </tr>
                    <tr>
                        <!-- <td>4302815</td> -->
                        <td>Robot Assisted Laparoscopic Coronary Artery Bypass</td>
                        <td>37</td>
                        <td>37</td>
                    </tr>
                    <tr>
                        <!-- <td>4304688</td> -->
                        <td>Double Valve Replacement</td>
                        <td>75</td>
                        <td>79</td>
                    </tr>
                </tbody>
            </table>

            <h3>3.3. Frequency by Procedure</h3>
            <div style="overflow-x: auto;">
                <table class="summary-table">
                    <thead>
                        <tr>
                            <th scope="col">Procedure</th>
                            <th scope="col">Prothrombin Time (PT)</th>
                            <th scope="col">Creatinine Ratio </th>
                            <th scope="col">Glucose IV (dose mass)</th>
                            <th scope="col">LDH Panel </th>
                            <th scope="col">Glycosylated Haemoglobin</th>
                            <th scope="col">aPTT Ratio </th>
                            <th scope="col">LDH Urine</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>Atrioseptoplasty</td>
                            <td>371</td>
                            <td>832</td>
                            <td>406</td>
                            <td>182</td>
                            <td>57</td>
                            <td>100</td>
                            <td>168</td>
                        </tr>
                        <tr>
                            <td>Repair of tetralogy of Fallot</td>
                            <td>127</td>
                            <td>304</td>
                            <td>135</td>
                            <td>67</td>
                            <td>19</td>
                            <td>65</td>
                            <td>48</td>
                        </tr>
                        <tr>
                            <td>Replacement of aortic valve</td>
                            <td>452</td>
                            <td>489</td>
                            <td>232</td>
                            <td>135</td>
                            <td>43</td>
                            <td>37</td>
                            <td>86</td>
                        </tr>
                        <tr>
                            <td>Pericardiectomy</td>
                            <td>62</td>
                            <td>201</td>
                            <td>91</td>
                            <td>37</td>
                            <td>18</td>
                            <td>22</td>
                            <td>45</td>
                        </tr>
                        <tr>
                            <td>Replacement of mitral valve</td>
                            <td>1754</td>
                            <td>1582</td>
                            <td>751</td>
                            <td>408</td>
                            <td>134</td>
                            <td>170</td>
                            <td>335</td>
                        </tr>
                        <tr>
                            <td>Aortocoronary artery bypass graft</td>
                            <td>539</td>
                            <td>1704</td>
                            <td>823</td>
                            <td>492</td>
                            <td>165</td>
                            <td>148</td>
                            <td>340</td>
                        </tr>
                        <tr>
                            <td>Correction of ventricular septal defect</td>
                            <td>114</td>
                            <td>246</td>
                            <td>130</td>
                            <td>54</td>
                            <td>19</td>
                            <td>47</td>
                            <td>58</td>
                        </tr>
                        <tr>
                            <td>Robot assisted laparoscopic coronary artery bypass</td>
                            <td>39</td>
                            <td>160</td>
                            <td>75</td>
                            <td>45</td>
                            <td>18</td>
                            <td>18</td>
                            <td>25</td>
                        </tr>
                        <tr>
                            <td>Double valve replacement</td>
                            <td>608</td>
                            <td>461</td>
                            <td>169</td>
                            <td>154</td>
                            <td>40</td>
                            <td>36</td>
                            <td>88</td>
                        </tr>
                    </tbody>
                </table>
            </div>

        </section>


        <section id="methods" class="report-card">
            <h2>4. Methods</h2>

            <h3>4.1. Study Design and Data Source</h3>
            <p>
                This retrospective cohort study utilized structured electronic health record (EHR) data from the
                <strong>Cardiovascular and Thoracic Surgery (CVTS)</strong> department, covering the period from
                <strong>January 2023 to May 2024</strong>. All source data were standardized and harmonized using the
                <strong>OMOP Common Data Model (CDM)</strong> to enable consistent longitudinal analysis across clinical
                domains.
            </p>




            <h3>4.2. Length of Stay Assessment</h3>
            <p>
                Length of Stay (LOS) was calculated for each CVTS admission as the difference between admission date and
                discharge date recorded in the <code>visit occurrence</code> table. LOS was treated as a continuous
                variable
                and subsequently categorized into clinically meaningful strata aligned with post-operative care
                practices
                and guideline-based expectations.
            </p>

            <h3>4.3. Clinical Measurement Selection</h3>
            <p>
                Laboratory and clinical measurement data were extracted from the <code>measurement</code> table and
                filtered
                to retain Lab markers considered relevant to post-operative recovery and Enhanced Recovery After Surgery
                (<strong>ERAS</strong>) pathways. These included markers spanning:
            </p>
            <ul>
                <li>Pre-operative baseline assessment</li>
                <!-- <li>Intra-operative physiological impact</li> -->
                <li>Post-operative recovery and complication monitoring</li>
            </ul>
            <p>
                Selection of Lab markers and temporal windows was informed by published ERAS and LOS-related literature,
                ensuring clinical relevance and interpretability.
            </p>

            <h3>4.4. Outcomes</h3>
            <p>
                Primary clinical outcomes were derived using standardized OMOP domain tables as follows:
            </p>
            <ul>
                <li>
                    <strong>30-day readmission:</strong> Defined as any inpatient visit occurring within 30 days of
                    discharge from the index CVTS admission.
                </li>
                <li>
                    <strong>30-day post-operative mortality:</strong> Determined using death records occurring within
                    30 days of the index discharge date.
                </li>
                <li>
                    <strong>Re-surgery:</strong> Identified as any subsequent CVTS-related procedure occurring after the
                    index surgery.
                </li>
            </ul>

            <h3>4.5. Exploratory Data Analysis</h3>

            <p>
                Exploratory data analysis (EDA) was performed to characterise patient demographics, clinical variables,
                and outcome distributions within the CVTS cohort. Particular emphasis was placed on examining
                therelationship between <strong>Length of Stay (LOS)</strong> and key post-operative outcomes.
            </p>

            <p>
                Outcomes were evaluated in relation to Length of Stay to assess whether variations in post-operative LOS
                were associated with differences in clinical outcomes. Comparative analyses were conducted across LOS
                strata to identify patterns suggestive of safe early discharge versus increased risk profiles.
            </p>

            <p>
                All analyses were performed using OMOP-standardized data structures to ensure transparency,
                reproducibility, and alignment with real-world evidence best practices.
            </p>

            <h3>4.6. Ethical and Data Governance Considerations</h3>
            <p>
                All data used in this study were de-identified using PrivacyBridgeAI prior to analysis. The study
                involved retrospective
                analysis of routinely collected clinical data and did not influence patient care decisions.
            </p>

            <section id="ethical" class="report-card">
                <h3>4.7. Ethical and Data Governance Considerations</h3>
                <p>
                    All data used in this study were de-identified using the <strong>PrivacyBridgeAI</strong>
                    <!-- <a href="#ref2" style="text-decoration: none; color: var(--accent); font-weight: bold;">[2]</a> -->
                    prior to analysis. The study involved retrospective analysis of routinely collected clinical data
                    processed on the <strong>Bridge Cloud</strong> platform
                    <a href="#ref2" style="text-decoration: none; color: var(--accent); font-weight: bold;">[2]</a>
                    and did not influence patient care decisions.
                </p>
            </section>

        </section>


        <section id="data-analysis" class="report-card">
            <h2>5. Data Analysis</h2>
            <h3>5.1. Mortality Rate</h3>
            <p>
                Mortality was assessed overall and by gender for 1,147 patients who underwent cardiovascular and
                thoracic surgery.
            </p>

            <table class="summary-table">
                <thead>
                    <tr>
                        <th scope="col">Gender</th>
                        <th scope="col">Total Patients</th>
                        <th scope="col">Deaths</th>
                        <th scope="col">Mortality (%)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <th scope="row">All</th>
                        <td>1147</td>
                        <td>90</td>
                        <td>7.85</td>
                    </tr>
                    <tr>
                        <th scope="row">Male</th>
                        <td>666</td>
                        <td>54</td>
                        <td>8.11</td>
                    </tr>
                    <tr>
                        <th scope="row">Female</th>
                        <td>481</td>
                        <td>36</td>
                        <td>7.48</td>
                    </tr>
                </tbody>
            </table>
            <div class="figure-row">
                <figure class="chart">
                    <img src="images/mortality_age_categorisation.png" alt="Age distribution of patients who died">
                    <figcaption>
                        Figure 5.1.1. Age categorization of patients who died, highlighting higher mortality in older
                        age groups.
                    </figcaption>
                </figure>
                <figure class="chart">
                    <img src="images/days_from_procedure_to_death_hist.png"
                        alt="Distribution of days from procedure to death" id="figure-5-1-2">
                    <figcaption>
                        Figure 5.1.2. Distribution of days from procedure to death; the majority of deaths occurred
                        within 30 days after surgery, with relatively few late events.
                    </figcaption>
                </figure>
            </div>


            <h3>5.2. Length of Stay</h3>
            <p>
                Overall, LOS demonstrated a right-skewed distribution, with the majority of patients being discharged
                within the first few weeks following surgery. The mean LOS was 14.5 days, while the median LOS was 11.0
                days, indicating that a relatively small subset of patients experienced prolonged hospitalizations,
                thereby increasing the overall average LOS.
            </p>
            <div class="figure-row">
                <figure class="chart">
                    <img src="images/percentage_distribution_los.png" alt="Age distribution of patients who died">
                    <figcaption>Figure 5.2.1. Distribution of length of stay (LOS) for all patients, showing
                        that most patients were discharged within the first few weeks </figcaption>
                </figure>
                <!-- <figure class="chart">
                    <img src="images/average_los_age-scatterplot.png" alt=""></img>
                    <figcaption>Figure 5.2.2. Frequency distribution of length of stay (LOS), showing that most patients
                        were discharged within the first few weeks after surgery.</figcaption>
                </figure> -->
                <figure class="chart">
                    <img src="images/length of each patient.png" alt="Length of Stay of Each Patient"></img>
                    <figcaption>Figure 5.2.2. Length of stay (LOS) by gender, comparing the number of male and female
                        patients across stay durations.</figcaption>
                </figure>
                <figure class="chart">
                    <img src="images/Average_los_with_procedure.png" alt="Average Length of Stay upon each Procedure">
                    <figcaption>Figure 5.2.3. Median length of stay for each surgical procedure. </figcaption>
                </figure>
                <p><i>Analysis: "Repair of tetralogy of fallot" surgeries resulted in the longest average hospital stay
                        (43 days), while "Replacement of mitral valve" had the shortest average stay of 14 days among
                        the analyzed procedures.</i></p>
                <p>

                </p>
            </div>
            <h3>5.3. Re-Admission</h3>
            <p>
                Thirty-day readmission was assessed for all CVTS discharges by identifying subsequent inpatient visits
                recorded in the OMOP visit occurrence table and linking them back to the index surgical admission. The
                primary objective was to evaluate time to readmission and examine whether earlier discharge was
                associated with an increased likelihood of unplanned hospital return.
            </p>
            <p>
                The distribution of time to readmission (0–90 days) showed a pronounced concentration of readmissions
                occurring shortly after discharge, with a gradual tapering over time. A substantial proportion of
                readmissions occurred within the first 30 days, as highlighted by the vertical threshold line,
                indicating a period of heightened vulnerability following discharge. Beyond 30 days, readmissions were
                more dispersed, suggesting a mix of delayed postoperative complications and disease progression rather
                than immediate post-surgical issues.
            </p>
            <div class="figure-row">
                <figure class="chart">
                    <img src="images/readmission.png" alt="Age distribution of patients who died">
                    <figcaption>Figure 5.3.1: Distribution of Time to Readmission (0–90 Days) Histogram showing the
                        frequency of patient returns relative to days post-discharge.</figcaption>
                </figure>
                <figure class="chart">
                    <img src="images/readmission_categorisation.png" alt="Age distribution of patients who died">
                    <figcaption>Figure 5.3.2: Proportion of Readmissions by Category Breakdown of patient readmissions
                        classified as Early (≤30 days), Normal, or Late.</figcaption>
                </figure>
                <figure class="chart">
                </figure>
            </div>
            <p>
                To further characterise this pattern, readmissions were categorised into early (≤30 days), normal (31–90
                days), and late (>90 days) groups. Early readmissions constituted the largest share, accounting for
                45.1% of all readmitted patients, followed by normal readmissions at 28.1%, and late readmissions at
                26.8%. The predominance of early readmissions suggests that nearly half of hospital returns occurred
                during the immediate post-discharge phase, a period commonly associated with surgical complications,
                inadequate recovery, or suboptimal discharge planning.
            </p>

        </section>


        <section id="results" class="report-card">
            <h2>6. Results</h2>
            <h3>6.1. Peri‑Operative Lab marker Trends Analysis</h3>
            <p>
                For each of the nine index procedures, patient‑level line plots were generated for all study Lab markers
                (for example, creatinine in peritoneal fluid/serum, lactate, troponin, coagulation and electrolyte
                markers). Measurements were time‑aligned to the day of surgery (t = 0), so that both pre‑operative (t
                &lt; 0) and post‑operative (t &gt; 0) trajectories could be visualised on the same scale.
            </p>
            <p>
                Plots were produced in batches of 25 patients per procedure, with a vertical dashed line marking the
                procedure time and horizontal reference bands showing expected ranges. These peri‑operative profiles
                were used to screen for Lab marker excursions after surgery, compare patterns across procedures, and
                identify markers associated with prolonged length of stay, complications or 30‑day readmission.
            </p>
            <!-- <h3>6.2. Post‑Operative Biomarker Trends Analysis</h3>
            <p>
                Post‑operative trajectories (t &gt; 0) of key biomarkers were examined to characterise recovery patterns
                after surgery. For each procedure, line plots and summary statistics were used to assess how quickly
                markers such as creatinine ratio, lactate, troponin and coagulation parameters returned to their
                expected reference ranges.
            </p>
            <p>
                Patients with sustained post‑operative abnormalities or sharp rises in these biomarkers were flagged and
                compared with those showing rapid normalisation in terms of length of stay, 30‑day readmission,
                re‑operation and post‑operative mortality. This analysis helped identify post‑operative risk signatures
                that may be relevant for ERAS‑guided monitoring and discharge decisions.
            </p>
            <div class="figure-row">
                <figure class="chart">
                    <img src="images/Creatinine_in_peritoneal_fluid___serum.png"
                        alt="Creatinine in peritoneal fluid/serum vs time for a CVTS procedure">
                    <figcaption>
                        Figure 6.1. Creatinine in peritoneal fluid / serum over time for patients undergoing a selected
                        CVTS procedure, aligned at the day of surgery (t = 0). Pre‑operative values are mostly within
                        the reference band, while some patients show post‑operative rises.
                    </figcaption>
                </figure>

                <figure class="chart">
                    <img src="images/Prothrombin_time__PT.png" alt="Prothrombin time vs time for a CVTS procedure">
                    <figcaption>
                        Figure 6.2. Prothrombin time (PT) trajectories around surgery for a CVTS procedure cohort,
                        demonstrating stable pre‑operative PT with substantial post‑operative variability and occasional
                        extreme prolongation.
                    </figcaption>
                </figure>
            </div> -->

            <h3>6.2.1. Interactive Lab marker Analysis</h3>
            <div class="interactive-container">

                <p>Select a procedure and a measurement to view the specific analysis plot.</p>
                <div class="control-row">
                    <div class="control-group">
                        <label for="procedure-select">Procedure</label>
                        <select id="procedure-select">
                            <option value="">-- Select Procedure --</option>
                            <option value="4012932">Atrioseptoplasty (4012932)</option>
                            <option value="4019929">Repair of tetralogy of Fallot (4019929)</option>
                            <option value="4095407">Replacement of aortic valve (4095407)</option>
                            <!-- <option value="4142628">Pericardiectomy (4142628)</option> -->
                            <option value="4203153">Replacement of mitral valve (4203153)</option>
                            <option value="4284104">Aortocoronary artery bypass graft (4284104)</option>
                            <option value="4294387">Correction of ventricular septal defect (4294387)</option>
                            <option value="4302815">Robot assisted laparoscopic coronary artery bypass (4302815)
                            </option>
                            <option value="4304688">Double valve replacement (4304688)</option>
                        </select>
                    </div>

                    <div class="control-group">
                        <label for="measure-select">Measurement (Lab marker)</label>
                        <select id="measure-select">
                            <option value="">-- Select Measurement --</option>
                            <option value="3034426">Prothrombin time (PT)</option>
                            <option value="42868738">Creatinine in peritoneal fluid / Serum</option>
                            <option value="3049746">Glucose IV (dose mass)</option>
                            <option value="3034022">Lactate dehydrogenase panel</option>
                            <option value="40765586">Glycosylated hemoglobin</option>
                            <option value="3041944">aPTT ratio</option>
                            <option value="3027193">Lactate dehydrogenase – urine</option>
                            <option value="3034426">Prothrombin time (PT)</option>
                            <option value="3005872">Hemoglobin [Presence] in Blood</option>
                            <option value="3050583">Platelets panel - Blood by Automated count</option>
                            <option value="42868738">Creatinine in peritoneal fluid/Creatinine in serum</option>
                            <option value="36305724">Potassium [Mass/volume] in Specimen</option>
                            <option value="36303488">Sodium [Mass/mass] in Specimen</option>
                            <option value="3034734">Urea [Mass/volume] in Urine</option>
                            <option value="40762632">Urea nitrogen [Moles/volume] in Blood</option>
                            <option value="1761868">Lipid panel - Serum or Plasma</option>
                            <!-- <option value="3018056">Glucose PO (dose mass)</option>
                            <option value="40761507">Platelet morphology panel</option>
                            <option value="1988947">Procalcitonin</option>
                            <option value="40762141">Lactate / pyruvate ratio</option> -->
                            <!-- <option value="3002937">Fibrinogen</option>
                            <option value="3017250">Creatinine – urine</option>
                            <option value="3021337">Troponin I (cardiac)</option> -->
                        </select>
                    </div>
                </div>
                <iframe id="plot-frame" src="about:blank" title="Data Analysis Plot"></iframe>
            </div>



            <!-- <h3>6.3. Length of stay and mortality</h3>
            <p>
            Patients who died had markedly longer total and post‑procedure hospital stays, with a broader spread and more extreme outliers than survivors, indicating that mortality was often preceded by prolonged and complicated admissions.
            </p>

            <div class="figure-row">
                <figure class="chart">
                    <img src="images/mortality_los_dependecy.png"
                        alt="Boxplot of length of stay by death status and LOS type">
                    <figcaption>
                    Figure 6.3. Boxplots of total and post‑procedure length of stay (LOS) for non‑deceased and deceased patients, showing higher and more variable LOS among those who died.
                    </figcaption>
                </figure>
            </div> -->


        </section>


        <section id="conclusion" class="report-card">
            <h2>7. Conclusion</h2>
            <h3>7.1. Length of stay and timing of death</h3>
            <p>
                To assess how mortality relates to hospital stay, two complementary analyses were performed. First,
                boxplots of total and post‑procedure length of stay were stratified by death status. Deceased patients
                showed higher median LOS and a wider spread with many extreme outliers, indicating that deaths were
                often preceded by prolonged and complicated admissions.
            </p>
            <p>
                Second, a histogram of days from procedure to death <a href="#figure-5-1-2">Figure 5.1.2.</a> showed
                that most deaths occurred within the first 30 days after surgery, with only a small number of late
                deaths beyond 60–90 days. This pattern suggests that the early post‑operative period is the highest‑risk
                window and that prolonged LOS in this phase may signal deteriorating clinical status.
            </p>
            <!-- <p>
            Although a broad panel of ERAS‑relevant laboratory measurements was initially considered, only a subset of biomarkers had sufficient peri‑ and post‑operative data for meaningful time‑series analysis. The final CVTS biomarker analysis therefore focused on coagulation, renal and metabolic markers listed below.
            </p> -->

            <!-- <table class="summary-table">
            <thead>
                <tr>
                <th scope="col">Measurement Concept Id</th>
                <th scope="col">Biomarker used in analysis</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                <td>3034426</td>
                <td>Prothrombin time (PT)</td>
                </tr>
                <tr>
                <td>42868738</td>
                <td>Creatinine in peritoneal fluid / Creatinine in serum</td>
                </tr>
                <tr>
                <td>049746</td>
                <td>Glucose IV (dose mass)</td>
                </tr>
                <tr>
                <td>3034022</td>
                <td>Lactate dehydrogenase panel – serum or plasma</td>
                </tr>
                <tr>
                <td>40765586</td>
                <td>Glycated haemoglobin (long‑term glucose)</td>
                </tr>
                <tr>
                <td>3041944</td>
                <td>Activated partial thromboplastin time (aPTT)</td>
                </tr>
                <tr>
                <td>3027193</td>
                <td>Lactate dehydrogenase – urine</td>
                </tr>
            </tbody>
            </table> -->
            </br>

            <p>
                Overall, the analysis suggests that extended total and post‑procedure LOS is strongly associated with
                in‑hospital mortality, re-admission and complications highlighting the need for early identification of
                patients whose recovery deviates from the expected trajectory.
            </p>
            <h3>7.2. Length of Stay and Mortality</h3>
            <p>
                To explore the relationship between hospital stay and mortality, boxplots were generated for total
                length of stay and post‑procedure length of stay, stratified by death status (non‑deceased vs deceased).
                Both metrics showed higher medians and wider IQRs in the deceased group, with a greater number of
                extreme outliers, suggesting that prolonged admissions and complicated post‑operative courses were more
                common among patients who died.
            </p>
            <p>
                In contrast, non‑deceased patients had shorter and more tightly clustered stays, particularly for
                post‑procedure LOS, consistent with smoother recoveries and earlier discharge under ERAS pathways.
            </p>
            </br>
            <p>
                Out of the 90 deaths observed in the CVTS data, 84 death occurred for the listed surgery and 73 occurred
                within 30 days of surgery, indicating that early post‑operative mortality accounts for the vast majority
                of fatal events and highlighting the first month after surgery as the highest‑risk period for patients.
            </p>
            <div class="figure-row">
                <figure class="chart">
                    <img src="images/los_vs_mortality.png"
                        alt="Distribution of total length of stay stratified by in-hospital mortality status">
                    <figcaption>
                        Figure 7.2.1. Total length of stay (LOS) by in‑hospital mortality status (is_death = 0 vs 1),
                        showing longer and more variable LOS among patients who died.
                    </figcaption>
                </figure>

                <figure class="chart">
                    <img src="images/plos_vs_mortality.png"
                        alt="Distribution of post-procedure length of stay stratified by in-hospital mortality status">
                    <figcaption>
                        Figure 7.2.2. Post‑procedure length of stay (PLOS) by in‑hospital mortality status (is_death = 0
                        vs 1), highlighting prolonged post‑operative stays in the mortality group.
                    </figcaption>
                </figure>
            </div>
            <h3>7.3. Length of Stay and Complications</h3>
            <p>
                Length of stay (LOS) was analysed in relation to post-operative complication status to assess the impact
                of complications on hospital utilisation. Two LOS measures were considered: <strong>total visit length
                    of stay</strong> and <strong>post-procedure length of stay (PLOS)</strong>.
            </p>

            <div class="figure-row">
                <figure class="chart">
                    <img src="images/los_vs_complication.png"
                        alt="Distribution of total length of stay stratified by occurrence of post-operative complications">
                    <figcaption>
                        Figure 7.3.1. Total LOS by post‑operative complication status (is_complication_happened = 0 vs
                        1), with longer stays observed when complications occurred.
                    </figcaption>
                </figure>

                <figure class="chart">
                    <img src="images/plos_vs_complicatons.png"
                        alt="Distribution of post-procedure length of stay stratified by occurrence of post-operative complications">
                    <figcaption>
                        Figure 7.3.2. PLOS by post‑operative complication status (is_complication_happened = 0 vs 1),
                        demonstrating extended post‑procedure stays in complicated cases.
                    </figcaption>
                </figure>
            </div>
            <p>
                Overall, both total LOS and post-procedure LOS were consistently <strong>longer among patients who
                    developed complications</strong>, demonstrating a strong association between post-operative
                complications and increased inpatient hospital stay. These findings underscore the <strong>significant
                    resource burden</strong> imposed by complications and highlight the importance of <strong>preventive
                    strategies and early complication management</strong> to reduce prolonged hospitalisation.
            </p>
            <h3>7.4. Length of Stay and Readmission</h3>
            <p>
                The relationship between length of stay (LOS) and 30-day readmission was examined to assess whether
                longer index hospitalisations were associated with an increased likelihood of subsequent inpatient
                readmission. Both <strong>total visit length of stay</strong> and <strong>post-procedure length of stay
                    (PLOS)</strong> were analysed in relation to readmission status.
            </p>
            <div class="figure-row">
                <figure class="chart">
                    <img src="images/los_vs_readmission.png"
                        alt="Distribution of total length of stay stratified by 30-day readmission status">
                    <figcaption>
                        Figure 7.4.1. Total LOS by 30‑day readmission status (is_readmitted = 0 vs 1), suggesting that
                        patients who were readmitted often had longer index admissions.
                    </figcaption>
                </figure>

                <figure class="chart">
                    <img src="images/plos_vs_readmission.png"
                        alt="Distribution of post-procedure length of stay stratified by 30-day readmission status">
                    <figcaption>
                        Figure 7.4.2. PLOS by 30‑day readmission status (is_readmitted = 0 vs 1), indicating that
                        prolonged post‑operative stays were associated with subsequent readmissions.
                    </figcaption>
                </figure>
            </div>
            <p>
                Overall, these findings suggest a meaningful association between <strong>prolonged length of stay during
                    the index admission</strong>—particularly post-procedure LOS—and subsequent 30-day readmission.
                Extended hospitalisation may serve as a marker of post-operative complexity or incomplete recovery,
                highlighting the importance of targeted discharge planning and post-discharge follow-up for patients
                with longer initial stays.
            </p>




        </section>


        <section id="references" class="report-card">
            <h2>8. References</h2>
            <ol style="padding-left: 20px; line-height: 1.6; font-size: 0.9rem;">
                <li id="ref1">
                    Engelman, Daniel T., Walid Ben Ali, Judson B. Williams, et al. "Guidelines for Perioperative Care in
                    Cardiac
                    Surgery: Enhanced Recovery After Surgery Society Recommendations." <i>JAMA Surgery</i> 154, no. 8
                    (2019):
                    755–766. doi:10.1001/jamasurg.2019.1153.
                </li>
                <li id="ref2">
                    Bridge Cloud. "Bridge Cloud Platform." Miimansa (2024).
                    Available at: <a href="https://medbridgeai.miimansa.com/" target="_blank"
                        style="color: var(--accent);">https://medbridgeai.miimansa.com/</a>
                </li>
            </ol>
        </section>


        <section id="conclusion" class="report-card">
            <h2>9. Appendix</h2>
            <h3>9.1. Biochemical Analytes and Laboratory Markers</h3>
            <table class="summary-table">
                <thead>
                    <tr>
                        <!-- <th scope="col">Measurement Concept ID</th> -->
                        <th scope="col">Lab marker / Panel</th>
                        <th scope="col">Distinct Patient Count</th>
                        <th scope="col">Distinct Measurement Count</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <!-- <td>3034426</td> -->
                        <td>Prothrombin Time (PT)</td>
                        <td>1139</td>
                        <td>8971</td>
                    </tr>
                    <tr>
                        <!-- <td>42868738</td> -->
                        <td>Creatinine in Peritoneal Fluid / Creatinine in Serum</td>
                        <td>1141</td>
                        <td>8193</td>
                    </tr>
                    <tr>
                        <!-- <td>3049746</td> -->
                        <td>Glucose IV (dose mass)</td>
                        <td>1126</td>
                        <td>4313</td>
                    </tr>
                    <tr>
                        <!-- <td>3034022</td> -->
                        <td>Lactate dehydrogenase panel – serum or plasma</td>
                        <td>1071</td>
                        <td>2653</td>
                    </tr>
                    <tr>
                        <!-- <td>40765586</td> -->
                        <td>Glycosylated hemoglobin (long‑term glucose)</td>
                        <td>1070</td>
                        <td>1881</td>
                    </tr>
                    <tr>
                        <!-- <td>3041944</td> -->
                        <td>aPTT (activated partial thromboplastin time) ratio</td>
                        <td>864</td>
                        <td>1614</td>
                    </tr>
                    <tr>
                        <!-- <td>3027193</td> -->
                        <td>Lactate Dehydrogenase – urine</td>
                        <td>684</td>
                        <td>1254</td>
                    </tr>
                    <tr>
                        <!-- <td>3018056</td> -->
                        <td>Glucose PO (dose mass)</td>
                        <td>322</td>
                        <td>510</td>
                    </tr>
                    <tr>
                        <!-- <td>40761507</td> -->
                        <td>Platelet Morphology Panel – blood</td>
                        <td>377</td>
                        <td>428</td>
                    </tr>
                    <tr>
                        <!-- <td>1988947</td> -->
                        <td>Procalcitonin – Serum / Plasma</td>
                        <td>105</td>
                        <td>181</td>
                    </tr>
                    <tr>
                        <!-- <td>40762141</td> -->
                        <td>Lactate / Pyruvate Ratio – Blood</td>
                        <td>94</td>
                        <td>107</td>
                    </tr>
                    <tr>
                        <!-- <td>3002937</td> -->
                        <td>Fibrinogen – Platelet Poor Plasma</td>
                        <td>17</td>
                        <td>31</td>
                    </tr>
                    <tr>
                        <!-- <td>3017250</td> -->
                        <td>Creatinine – Urine</td>
                        <td>20</td>
                        <td>23</td>
                    </tr>
                    <tr>
                        <!-- <td>40760092</td> -->
                        <td>Proline / Creatinine Ratio – 24‑h Urine</td>
                        <td>19</td>
                        <td>22</td>
                    </tr>
                    <tr>
                        <!-- <td>3032932</td> -->
                        <td>Creatinine – 24‑h Urine (mass or moles)</td>
                        <td>18</td>
                        <td>21</td>
                    </tr>
                    <tr>
                        <!-- <td>3019210</td> -->
                        <td>Glucose – Body Fluid</td>
                        <td>14</td>
                        <td>19</td>
                    </tr>
                    <tr>
                        <!-- <td>3008338</td> -->
                        <td>Lactate Dehydrogenase – Body Fluid</td>
                        <td>12</td>
                        <td>15</td>
                    </tr>
                    <tr>
                        <!-- <td>36307891</td> -->
                        <td>Screening Panel</td>
                        <td>9</td>
                        <td>9</td>
                    </tr>
                    <tr>
                        <!-- <td>3020682</td> -->
                        <td>Albumin / Creatinine Ratio – Urine</td>
                        <td>7</td>
                        <td>8</td>
                    </tr>
                    <tr>
                        <!-- <td>3038383</td> -->
                        <td>Fibrin D‑dimer – Titer</td>
                        <td>7</td>
                        <td>8</td>
                    </tr>
                    <tr>
                        <!-- <td>3001123</td> -->
                        <td>Platelet Mean Volume – Blood</td>
                        <td>6</td>
                        <td>7</td>
                    </tr>
                    <tr>
                        <!-- <td>3010476</td> -->
                        <td>Phosphoserine / Creatinine Ratio – Urine</td>
                        <td>6</td>
                        <td>7</td>
                    </tr>
                    <tr>
                        <!-- <td>3021337</td> -->
                        <td>Troponin I (Cardiac) – Serum / Plasma</td>
                        <td>6</td>
                        <td>6</td>
                    </tr>
                    <tr>
                        <!-- <td>3000483</td> -->
                        <td>Glucose – blood</td>
                        <td>3</td>
                        <td>3</td>
                    </tr>
                    <tr>
                        <!-- <td>3038276</td> -->
                        <td>Urea / Creatinine Ratio – Urine</td>
                        <td>2</td>
                        <td>2</td>
                    </tr>
                    <tr>
                        <!-- <td>3015823</td> -->
                        <td>Fibrin D‑dimer – presence</td>
                        <td>2</td>
                        <td>2</td>
                    </tr>
                    <tr>
                        <!-- <td>3038404</td> -->
                        <td>Protein / Creatinine Ratio – 24‑h Urine</td>
                        <td>2</td>
                        <td>2</td>
                    </tr>
                    <tr>
                        <!-- <td>3037791</td> -->
                        <td>Protein / Creatinine Mass Ratio – 24‑h Urine</td>
                        <td>1</td>
                        <td>1</td>
                    </tr>
                    <tr>
                        <!-- <td>3049242</td> -->
                        <td>Von Willebrand Panel – Platelet Poor Plasma</td>
                        <td>1</td>
                        <td>1</td>
                    </tr>
                    <tr>
                        <!-- <td>36303398</td> -->
                        <td>Protein S antigen panel – Platelet Poor Plasma</td>
                        <td>1</td>
                        <td>1</td>
                    </tr>
                    <tr>
                        <!-- <td>3020287</td> -->
                        <td>Protein C activity – Platelet Poor Plasma</td>
                        <td>1</td>
                        <td>1</td>
                    </tr>
                </tbody>
            </table>
            <h3>9.2. Cohort Identification</h3>
            <p>
                CVTS-related hospital admissions were identified by linking visit occurrence records with:
            </p>
            <ul>
                <li>
                    Standardized procedure codes representing cardiovascular and thoracic surgical interventions, and
                </li>
                <li>
                    Department-level tags indicating care delivery within the CVTS service.
                </li>
            </ul>
            <p>
                Only inpatient visits associated with at least one qualifying CVTS procedure were included in the
                analysis.
            </p>
        </section>
    </main>
    <style>
        /* Animation to flash the reference yellow when clicked */
        @keyframes highlight-fade {
            0% {
                background-color: rgba(244, 125, 36, 0.3);
            }

            /* Your accent color */
            100% {
                background-color: transparent;
            }
        }

        .target-highlight {
            animation: highlight-fade 2s ease-out;
            border-radius: 4px;
            /* Optional rounded corners */
            padding: 4px;
            /* Adds a little breathing room for the highlight */
        }
    </style>

    <script>
        document.addEventListener('DOMContentLoaded', function () {
            // 1. Select all links that start with '#' (internal anchors)
            const anchors = document.querySelectorAll('a[href^="#"]');

            anchors.forEach(anchor => {
                anchor.addEventListener('click', function (e) {
                    // Get the target ID (e.g., "ref1")
                    const targetId = this.getAttribute('href').substring(1);
                    const targetElement = document.getElementById(targetId);

                    if (targetElement) {
                        e.preventDefault(); // Stop the instant jump

                        // 2. Scroll the element to the CENTER of the viewport
                        targetElement.scrollIntoView({
                            behavior: 'smooth',
                            block: 'center'
                        });

                        // 3. Add a temporary highlight effect
                        targetElement.classList.remove('target-highlight'); // reset if already active
                        void targetElement.offsetWidth; // trigger reflow to restart animation
                        targetElement.classList.add('target-highlight');

                        // Optional: Update URL hash without jumping
                        history.pushState(null, null, '#' + targetId);
                    }
                });
            });
        });
    </script>

</body>

</html>